I carry out clinical routine on Radionuclide Receptor therapy with radiopeptides labelled with β-emitters in endocrine malignancies, brain tumors, and others sstr positive malignances.
I work in the field of Radio Ligand therapy (RLT) with 177Lu-PSMA used to treat castration resistant prostate cancer patients.
I dedicate myself to scientific research on radiolabeled peptides, radioimmunotherapy, new radiopharmaceutical agents.